Skip to main content

Table 1 Clinical characteristics of patients (n = 24)

From: Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study

Clinical characteristics

Received CP (n = 14)

Without CP (n = 10)

P value

Demographics

 Gender

  Male, n (%)

8 (57)

7 (70)

0.678

  Female, n (%)

6 (43)

3 (30)

0.678

 Age, mean ± SE, y

64.6 ± 4.3

55.6 ± 4.8

0.177

  < 40 years, n (%)

1 (7)

1 (10)

1

  40–60 years, n (%)

3 (21)

5 (50)

0.204

  > 60 years, n (%)

10 (71)

4 (40)

0.211

APACHE II score, mean ± SE

12.2 ± 1.6

9.0 ± 0.8

0.121

With three or more comorbidities, n (%)

8 (57)

4 (40)

0.680

Main comorbidities

 Chronic obstructive pulmonary disease, n (%)

6 (43)

1 (10)

0.171

 Diabetes mellitus, n (%)

4 (29)

1 (10)

0.358

 Hypertension, n (%)

4 (29)

1 (10)

0.358

 Coronary heart disease, n (%)

4 (29)

0

0.114

Main complication

 Bacterial pneumonia, n (%)

9 (64)

3 (30)

0.213

 Hypoalbuminous edema, n (%)

8 (57)

3 (30)

0.240

 Respiratory fungal infection, n (%)

6 (43)

1 (10)

0.171

 Gastrointestinal hemorrhage, n (%)

2 (14)

0

0.493

  1. APACHE acute physiology and chronic health evaluation, CP convalescent plasma, SE stand error